정도경영


Jeong-Do Activities

‘Continuous Challenge to Pursue Health and Happiness for Humanity’ is vision of Dong-A Socio Group.

Jeong-Do Activities

Dong-A 鼎道 Way

donga-history
  • Hosted a ceremony to
    set out Jeong-Do
    Management
  • Certificate
  • CEO, Jung-Seok Kang
    has announced Dong-A
    Socio Group’s new vision
    system ‘Vision 2025’.
  • Obtained European
    Commission(EC) approval
    and launched Sivextro®
    (Tedizolid) in European
    countries
  • Released Motilitone®
    Dong-A’s third in-house
    developed original drug
    and a phytomedicine for
    functional dyspepsia
  • Released Zydena®, Dong-A’s second in-house developed original drug and an erectile dysfunction treatment
  • Released Stillen®, Dong-A’s first in-house developed original drug and a phytomedicine for gastrities
  • Honorary president, Shin-Ho kang
    has established a larger and bolder management philosophy.
  • As the harmfulness to human body of ‘Saeng-myeong su’, founder, Joong-Hee Kang stopped production and withdraw all the products distributed in the market to practice the value as a pharmaceutical company.
  • Joong-Hee Kang’s Wholesaler, a pharmaceutical and hygiene material wholesaler, began operations in Joonghak-dong, Jongro-gu, Seoul, Korea
  • Released Suganon®
    (Evogliptin) and Sugamet® - XR
    (combination product of
    Evogliptin and Metformin),
    Dong-A’s fifth in-house
    developed original drug and a
    type 2 diabetes treatmet